Janux Therapeutics, Inc. Common Stock (NASDAQ: JANX) last traded at $18.39, down 0.59% on the session. The quote above updates while this page is open; the figures below are drawn from Janux Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Janux Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker JANX. Its market capitalisation is $1.12 billion.
Valuation measures for Janux Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.12B |
|---|---|
| Enterprise value | $1.18B |
| Price / sales | 46.85 |
| Price / book | 1.21 |
| Beta | 1.12 |
Trailing-twelve-month figures tagged in Janux Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $24.00M |
|---|---|
| Net income (TTM) | -$102.59M |
| EPS (TTM) | -$1.64 |
| Operating margin | -598.15% |
| Return on equity | -11.06% |
| Cash | $27.77M |
Range and volume for JANX over the past 52 weeks.
| 52-week high | $35.34 |
|---|---|
| 52-week low | $12.12 |
| Volume | 1.17M |
| Average volume | 851.0K |
| Previous close | $18.50 |
Invest a chosen dollar amount in Janux Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell JANX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.